Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets

Clinical Science

Volumn 131, Issue 21, 2017, Pages 2561-2573

  Umpleby, A Margot ^a   Shojaee Moradie, Fariba ^a   Fielding, Barbara ^a   Li, Xuefei ^a   Marino, Andrea ^a   Alsini, Najlaa ^a   Isherwood, Cheryl ^a   Jackson, Nicola ^a   Ahmad, Aryati ^a,b   Stolinski, Michael ^a   Lovegrove, Julie A ^c   Johnsen, Sigurd ^a   Mendis, A S Jeewaka R ^a   Wright, John ^a   Wilinska, Malgorzata E ^d   Hovorka, Roman ^d   Bell, Jimmy D ^e,f   Louise Thomas, E ^e,f   Frost, Gary S ^g   Griffin, Bruce A ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b UNIVERSITI SULTAN ZAINAL ABIDIN   (Malaysia)

^c UNIVERSITY OF READING   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

^f UNIVERSITY OF WESTMINSTER   (United Kingdom)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN C2; LIPID; STABLE ISOTOPE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; CARBOHYDRATE DIET; FAT;

ADULT; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIETARY INTAKE; ENZYME ACTIVITY; HUMAN; INTRAABDOMINAL FAT; LIPID BLOOD LEVEL; LIPOGENESIS; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS FAT; SUGAR INTAKE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE; ADMINISTRATION AND DOSAGE; AGED; BLOOD; CARBOHYDRATE DIET; DIET RESTRICTION; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; LIVER; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PHARMACOLOGY; TIME FACTOR;

ADULT; AGED; CROSS-OVER STUDIES; DIETARY CARBOHYDRATES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASTING; FATS; HUMANS; LIPIDS; LIPOPROTEINS, VLDL; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OUTCOME ASSESSMENT (HEALTH CARE); TIME FACTORS; TRIGLYCERIDES;

EID: 85032440331     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20171208     Document Type: Article

References (43)

1. Hashimoto, E., Tokushige, K. and Ludwig, J. (2015) Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: current concepts and remaining challenges. Hepatol. Res. 45, 20-28
2. Stanhope, K.L., Schwarz, J.M. and Havel, P.J. (2013) Adverse metabolic effects of dietary fructose: results from the recent epidemiological, clinical, and mechanistic studies. Curr. Opin. Lipidol. 24, 198-206
3. Te Morenga, L.A., Howatson, A.J., Jones, R.M. and Mann, J. (2014) Dietary sugars and cardiometabolic risk: systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids. Am. J. Clin. Nutr. 100, 65-79
4. Lonardo, A., Sookoian, S., Pirola, C.J. and Targher, G. (2016) Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism 65, 1136-1150
5. Griffin, B.A., Freeman, D.J., Tait, G.W., Thomson, J, Caslake, M.J., Packard, C.J. et al. (1994) Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106, 241-253
6. Taskinen, M.R., Adiels, M., Westerbacka, J., Söderlund, S., Kahri, J., Lundbom, N. et al. (2011) Dual metabolic defects are required to produce hypertriglyceridemia in obese subjects. Arterioscler. Thromb. Vasc. Biol. 31, 2144-2150
7. Watts, G.F., Mandalia, S., Brunt, J.N., Slavin, B.M., Coltart, D.J. and Lewis, B. (1993) Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism 42, 1461-1467
8. Donnelly, K.L., Smith, C.I., Schwarzenberg, S.J., Jessurun, J., Boldt, M.D. and Parks, E.J. (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343-1351
9. Stanhope, K.L. (2016) Sugar consumption, metabolic disease and obesity: the state of the controversy. Crit. Rev. Clin. Lab. Sci. 53, 52-67
10. Schwarz, J.M., Neese, R.A., Turner, S., Dare, D. and Hellerstein, M.K. (1995) Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. J. Clin. Invest. 96, 2735-2743
11. Jebb, S.A., Lovegrove, J.A., Griffin, B.A., Frost, G.S., Moore, C.S., Chatfield, M.D. et al. (2010) Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. Am. J. Clin. Nutr. 92, 748-758
12. Szczepaniak, L.S., Nurenberg, P., Leonard, D., Browning, J.D., Reingold, J.S., Grundy, S. et al. (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of NAFLD in the general population. Am. J. Physiol. Endocrinol. Metab. 288, E462-E468
13. National Diet and Nutrition Survey (2014) Results from Year 1-4 (combined) of the Rolling Programme (2008/2009-2011/2012), Public Health England
14. Department of Health (1989) Dietary Sugars and Human Disease. Committee on Medical Aspects of Food Policy. Report on Health and Social Subjects No. 37, HMSO, London
15. Kelly, S.A., Summerbell, C., Rugg-Gunn, A.J., Adamson, A., Fletcher, E. and Moynihan, P.J. (2005) Comparison of methods to estimate non-milk extrinsic sugars and their application to sugars in the diet of young adolescents. Br. J. Nutr. 94, 114-124
16. Sarac, I., Backhouse, K., Shojaee-Moradie, F., Stolinski, M., Robertson, M.D., Bell, J.D. et al. (2012) Gender differences in VLDL1 and VLDL2 triglyceride kinetics and fatty acid kinetics in obese postmenopausal women and obese men. J. Clin. Endocrinol. Metab. 97, 2475-2481
17. Brackenridge, A.L., Jackson, N., Jefferson, W., Stolinski, M., Shojaee-Moradie, F, Hovorka, R. et al. (2009) Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids. Diabet. Med. 26, 532-539
18. McGee, K.C., Shahmanesh, M., Boothby, M., Nightingale, P., Gathercole, L.L., Tripathi, G. et al. Evidence for a shift to anaerobic metabolism in adipose tissue in efavirenz-containing regimens for HIV with different nucleoside backbones. Antivir. Ther. 17, 495-507
19. Thomas, E.L., Hamilton, G., Patel, N., O'Dwyer, R., Doré, C.J., Goldin, R.D. et al. (2005) Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 54, 122-127
20. Adiels, M., Taskinen, M.R., Packard, C.J., Caslake, M.J., Soro-Paavonen, A., Westerbacka, J. et al. (2006) Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49, 755-765
21. Adiels, M., Olofsson, S.O., Taskinen, M.R. and Boré n, J. (2008) Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 28, 1225-1236
22. Theytaz, F., Noguchi, Y., Egli, L., Campos, V., Buehler, T., Hodson, L. et al. (2012) Effects of supplementation with essential amino acids on intrahepatic lipid concentrations during fructose overfeeding in humans. Am. J. Clin. Nutr. 96, 1008-1016
23. Mittendorfer, B. and Sidossis, L.S. (2001) Mechanism for the increase in plasma triacylglycerol concentrations after consumption of short-term, high-carbohydrate diets. Am. J. Clin. Nutr. 73, 892-899
24. Gaw, A., Packard, C.J., Lindsay, G.M., Griffin, B.A., Caslake, M.J., Lorimer, A.R. et al. (1995) Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins. J. Lipid Res. 36, 158-171
25. Griffin, B.A. and Zampelas, A. (1995) Influence of dietary fatty acids on the atherogenic lipoprotein phenotype. Nutr. Res. Rev. 8, 1-26
26. Lambert, J.E., Ramos-Roman, M.A., Browning, J.D. and Parks, E.J. (2014) Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 146, 726-735
27. Timlin, M.T. and Parks, E.J. (2005) Temporal pattern of de novo lipogenesis in the postprandial state in healthy men. Am. J. Clin. Nutr. 81, 35-42
28. Stanhope, K.L., Schwarz, J.M., Keim, N.L., Griffen, S.C., Bremer, A.A., Graham, J.L. et al. (2009) Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Invest. 119, 1322-1334
29. Faeh, D., Minehira, K., Schwarz, J.M., Periasamy, R., Park, S. and Tappy, L. (2005) Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 54, 1907-1913
30. Bergman, E.N., Havel, R.J., Wolfe, B.M. and Bohmer, T. (1971) Quantitative studies of the metabolism of chylomicron triglycerides and cholesterol by liver and extrahepatic tissues of sheep and dogs. J. Clin. Invest. 50, 1831-1839
31. Parks, E.J., Krauss, R.M., Christiansen, M.P., Neese, R.A. and Hellerstein, M.K. (1999) Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J. Clin. Invest. 104, 1087-1096
32. Nielsen, S., Guo, Z., Johnson, C.M., Hensrud, D.D. and Jensen, M.D. (2004) Splanchnic lipolysis in human obesity. J. Clin. Invest. 113, 1582-1588
33. Klein, S. (2004) The case of visceral fat: argument for the defense. J. Clin. Invest. 113, 1530-1532
34. Jensen, M.D, Cardin, S., Edgerton, D. and Cherrington, A. (2003) Splanchnic free fatty acid kinetics. Am. J. Physiol. Endocrinol. Metab. 284, E1140-E1148
35. Abraha, A., Humphreys, S.M., Clark, M.L., Matthews, D.R. and Frayn, K.N. (1998) Acute effect of fructose on postprandial lipaemia in diabetic and non-diabetic subjects. Br. J. Nutr. 80, 169-175
36. Griffin, B.A. (2015) Relevance of liver fat to the impact of dietary extrinsic sugars on lipid metabolism. Proc. Nutr. Soc. 74, 208-214
37. Yao, Z. (2012) Human apolipoprotein C-III-a new intrahepatic protein factor promoting assembly and secretion of very low density lipoproteins. Cardiovasc. Hematol. Disord. Drug Targets 12, 133-140
38. World Health Organisation's Draft Guidelines on sugar intake for adults and children (2014) https://www.who.int/nutrition/sugars public consultation/en/(accessed 2 August 2015
39. Scientific Advisory Committee on Nutrition: Draft report on carbohydrates and health (2014) https://www.gov.uk/government/uploads/system/uploads/attachment data/file/445503/SACN Carbohydrates and Health.pdf (accessed 5 August 2015
40. Chung, M., Ma, J., Patel, K., Berger, S., Lau, J. and Lichtenstein, A.H. (2014) Fructose, high-fructose corn syrup, sucrose, and non-alcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. Am. J. Clin. Nutr. 100, 833-849
41. Schwarz, J.M., Noworolski, S.M., Wen, M.J., Dyachenko, A., Prior, J.L., Weinberg, M.E. et al. (2015) Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat. J. Clin. Endocrinol. Metab. 100, 2434-2442
42. Maersk, M., Belza, A., Stødkilde-Jørgensen, H., Ringgaard, S., Chabanova, E., Thomsen, H. et al. (2012) Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am. J. Clin. Nutr. 95, 283-289
43. Sevastianova, K., Santos, A., Kotronen, A., Hakkarainen, A., Makkonen, J., Silander, K. et al. (2012) Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am. J. Clin. Nutr. 96, 727-734